Where Will Anlon Healthcare Share Price Be in the Next 3 Years?

The Anlon Healthcare share price forecast for the next 3 years is a question on many investors’ minds as the stock trades at Rs 640, within a 52 week range of Rs 335 to Rs 748. This article lays out a scenario based Anlon Healthcare share price outlook for 2027, 2028 and 2030, built on the company’s fundamentals, sector trends and the key risks that could change the trajectory. Rather than a single number, the focus here is on the range of outcomes and the assumptions behind each one.

Click Here – Get Free Investment Predictions

Anlon Healthcare Company Overview

Anlon Healthcare manufactures pharmaceutical intermediates and active pharmaceutical ingredients for domestic and export formulators. Understanding the business model is the first step in framing any credible Anlon Healthcare share price forecast, because the durability of earnings ultimately decides where the stock trades.

Company	Anlon Healthcare
NSE Ticker	ANLON
CMP	Rs 640
52 Week High	Rs 748
52 Week Low	Rs 335
Market Cap	Rs 481 Cr
Stock PE	34.6
Book Value	Rs 116
ROE	21.1%
ROCE	27.1%
Dividend Yield	0%

Where Does Anlon Healthcare Share Price Stand Today?

The stock currently trades about 14 percent below its 52 week high of Rs 748, which means the market has already tempered some of its optimism. For anyone building a Anlon Healthcare share price forecast, this correction matters for the Anlon Healthcare share price forecast starting point, because entry valuations have a large bearing on 3 year returns.

At the current price, Anlon Healthcare commands a market capitalisation of Rs 481 Cr and trades at a price to earnings multiple of 34.6. The company generates a return on equity of 21.1% and a return on capital employed of 27.1%, which places it in the category of businesses with strong return ratios. These numbers anchor the Anlon Healthcare share price forecast scenarios that follow. How the broader Nifty 50 index trades over this period will also influence the multiple investors are willing to assign to the stock.

Anlon Healthcare Share Price Forecast: Key Growth Drivers for the Next 3 Years

Four forces are likely to shape the Anlon Healthcare share price forecast between now and 2030, and together they explain most of the dispersion in this Anlon Healthcare share price forecast. Each is discussed below with its likely direction of impact.

Earnings Trajectory and Return Ratios

Stock prices ultimately follow earnings. With strong return ratios at present, the pace at which profits compound over FY27 to FY30 will be the single biggest determinant of the Anlon Healthcare share price forecast actually playing out. Consistent earnings delivery tends to expand valuation multiples, while misses compress them quickly.

Structural Tailwinds in Indian Pharmaceuticals

The Indian pharmaceutical market continues to grow in high single to low double digits, supported by chronic disease prevalence, better diagnosis rates and premiumisation of therapies. Companies with strong brand equity and field force productivity, like Anlon Healthcare, are positioned to grow ahead of the market. Sector trends are visible in the Nifty Pharma index, which serves as a useful barometer for the space.

Within the space, investors often benchmark Anlon Healthcare against peers such as Alpa Laboratories, Amanta Healthcare and Aarey Drugs & Pharmaceuticals on growth and valuations before forming a view on the Anlon Healthcare share price forecast.

Company Specific Catalysts

The bull case for Anlon Healthcare rests on rising demand for pharma intermediates from domestic and export formulators and new product additions. If these play out on schedule, the Anlon Healthcare share price forecast for 2030 could gravitate toward the upper end of the scenario range discussed below.

Macro Environment and Liquidity

The RBI rate cycle, FII flows into Indian equities and overall market valuations will influence the multiple investors are willing to pay. A benign macro backdrop supports the optimistic end of any Anlon Healthcare share price forecast, while global risk aversion would do the opposite to the Anlon Healthcare share price outlook.

Anlon Healthcare Share Price Forecast 2027, 2028 and 2030: Scenario Analysis

The table below presents a scenario based Anlon Healthcare share price forecast using compounded annual growth assumptions applied to the current market price of Rs 640. These are illustrative ranges, not point predictions, and actual outcomes can fall outside them.

Year	Bear Case	Base Case	Bull Case	Assumption
2027	Rs 690	Rs 760	Rs 820	5% to 18% CAGR on CMP
2028	Rs 725	Rs 850	Rs 970	5% to 18% CAGR on CMP
2030	Rs 795	Rs 1,070	Rs 1,350	5% to 18% CAGR on CMP

In the base case scenario of this Anlon Healthcare share price forecast, the 2030 level works out to roughly Rs 1,070, implying steady compounding from today’s levels. The bull case of Rs 1,350 assumes rising demand for pharma intermediates from domestic and export formulators and new product additions delivers ahead of expectations, while the bear case of Rs 795 captures a scenario where growth stalls. That is an outcome band of about 24 percent to 111 percent over the period.

Consult a SEBI Registered Investment Advisor Before Acting on Any Forecast

Bull Case vs Bear Case for Anlon Healthcare Share Price

The Bull Case

The optimistic Anlon Healthcare share price forecast assumes rising demand for pharma intermediates from domestic and export formulators and new product additions. Combined with supportive sector conditions, this could lift both earnings and the valuation multiple, pushing the stock toward Rs 1,350 by 2030.

The Bear Case

The cautious view centres on the fact that client concentration and pricing pressure in commodity pharma intermediates are key risks. If these pressures dominate, the Anlon Healthcare share price forecast would skew toward the lower band and the stock could stagnate near Rs 795 even by 2030, underperforming broader indices.

Key Risks That Could Change the Anlon Healthcare Share Price Outlook

• Execution risk: Delays in strategy execution or capacity plans would push the earnings trajectory below the base case assumed in this Anlon Healthcare share price forecast.
• Valuation risk: At a PE of 34.6, any earnings disappointment can trigger sharp multiple compression before fundamentals stabilise.
• Sector risk: Client concentration and pricing pressure in commodity pharma intermediates are key risks.
• Macro risk: A global slowdown, adverse FII flows or unexpected rate moves would compress equity valuations across the market.
• Regulatory risk: Policy, tax or compliance changes affecting the sector can alter the earnings outlook with little warning.

Is Anlon Healthcare Worth Watching for the Long Term?

For long term investors, the relevant question is not just where the Anlon Healthcare share price forecast lands in 2030 or what any single Anlon Healthcare share price forecast says today, but whether the business can compound capital through cycles. The company’s positioning around rising demand for pharma intermediates from domestic and export formulators and new product additions gives it a credible growth story, while the risks outlined above define what must be monitored each quarter.

Investors should track quarterly earnings, management commentary and sector data rather than anchoring to any single number from a Anlon Healthcare share price outlook. Historically, staying focused on business fundamentals has served investors better than chasing price targets, and consulting a SEBI registered advisor before investing remains the prudent approach.

Download the Univest iOS App or Univest Android App to track Anlon Healthcare share price live.

Conclusion

The Anlon Healthcare share price forecast for the next 3 years spans Rs 795 to Rs 1,350 by 2030 under the scenarios discussed, with a base case near Rs 1,070. Any credible Anlon Healthcare share price forecast must be updated as facts change, and the path will be decided by earnings delivery, rising demand for pharma intermediates from domestic and export formulators and new product additions and the broader market environment. Treat these ranges as a framework for thinking, not a promise of outcomes, and revisit the assumptions as new results come in. Consult a SEBI registered investment advisor before making any investment decision.

What is the Anlon Healthcare share price forecast for the next 3 years?

Ans. The Anlon Healthcare share price forecast for the next 3 years is scenario based rather than a single number. By 2030, the illustrative range spans Rs 795 in the bear case to Rs 1,350 in the bull case, with a base case near Rs 1,070, depending on earnings delivery and market conditions.

What is the Anlon Healthcare share price forecast for 2027?

Ans. For 2027, the scenario range works out to Rs 690 to Rs 820, with a base case around Rs 760. This assumes compounding on the current price of Rs 640 and is illustrative, not a guaranteed outcome.

What is the Anlon Healthcare share price forecast for 2028?

Ans. The 2028 scenario range is Rs 725 to Rs 970, with the base case near Rs 850. Actual levels will depend on earnings growth, sector trends and overall market valuations at the time.

What is the current share price of Anlon Healthcare?

Ans. Anlon Healthcare currently trades at around Rs 640 on the NSE, within a 52 week range of Rs 335 to Rs 748. Prices change continuously during market hours, so check live quotes before acting.

Is Anlon Healthcare a good stock for the long term?

Ans. Anlon Healthcare has a credible long term story built on rising demand for pharma intermediates from domestic and export formulators and new product additions, but it also carries risks since client concentration and pricing pressure in commodity pharma intermediates are key risks. Long term suitability depends on your risk profile and portfolio, so consult a SEBI registered investment advisor before investing.

What is the Anlon Healthcare share price outlook for 2030?

Ans. The Anlon Healthcare share price outlook for 2030 spans Rs 795 to Rs 1,350 across bear and bull scenarios. Where the stock actually lands will be driven by profit growth, valuation multiples and macro conditions closer to that date.

What are the key risks to the Anlon Healthcare share price forecast?

Ans. The main risks are execution delays, valuation compression from the current PE of 34.6, sector specific pressures, macro shocks and regulatory changes. Any of these can push the stock below the base case scenario discussed in this article.